Consumer goods executive Elio Leoni Sceti is joining Coty Inc. as chief executive officer. Sceti, 49, comes to Coty from European frozen food company Iglo Group, where he served as CEO since May 2013. He takes over from Bart Becht, interim CEO and chairman at Coty. Coty said Monday that Sceti is
Steve Rempel has joined Rite Aid Corp. as senior vice president and chief information officer. Rite Aid said Monday that Rempel will oversee all aspects of the company’s technology and information operations, including computer systems, network infrastructure, telecommunications and data security.
Discount Drug Mart is slated to begin carrying Bikini Ready Lifestyle and SlimTrim dietary supplement products from Inergetics Inc. Inergetics said Bikini Ready Lifestyle and SlimTrim are due to hit shelves at Discount Drug Mart’s 72 stores in Ohio this month.
Aurobindo Pharma Ltd. has received the first Abbreviated New Drug Application approval from the Food and Drug Administration for cefixime for oral suspension, USP, 100 mg/5 ml and 200 mg/5 ml. Cefixime for O.S. is bioequivalent and therapeutically equivalent to Suprax from Lupin Pharmaceuticals Inc.
Specialty drugs and branded drug price inflation are contributing to a projected rise in U.S. pharmacy costs over the next couple of years, according to an analysis by Aon Hewitt.
Walgreens stores nationwide have begun selling red noses in support of Red Nose Day, which runs from April 17 to May 30. Created in the United Kingdom, Red Nose Day brings people together every two years to do something funny to raise money for charity. To start the first Red Nose Day
London Drugs has partnered with LED Dental Inc. in a pilot program to provide free oral cancer screenings. In the pilot, LED Dental is providing its VELscope Vx Enhanced Oral Assessment System for screenings at 12 London Drugs pharmacies in the lower mainland area of British Columbia.
John Castellani, president and chief executive officer of Pharmaceutical Research and Manufacturers of America (PhRMA), plans to retire next year. PhRMA said Thursday that Castellani’s retirement is slated to go into effect Jan. 1, 2016.
Sandoz has received Food and Drug Administration approval for Glatopa, a treatment for multiple sclerosis (MS). The Novartis subsidiary said Thursday that its product is the first generic version of Teva’s Copaxone (glatiramer acetate injection) 20 mg/ml once-daily MS therapy.
NBTY Inc. has appointed four senior executives to its management team, who will be charged with spearheading growth initiatives for the nutritional supplement maker and marketer’s branded businesses. NBTY said Thursday that Andre Branch has joined the company as chief marketing officer.
Walgreens Boots Alliance Inc. has the size and scope to be “one of the companies that helps shape the future of health care, pharmacy and retail on a global basis,” executive vice president and acting chief executive officer Stefano Pessina said at the company’s Analyst Day event.
Medline Industries Inc. has formed an integrated electronic purchasing partnership with Brightree, a provider of cloud-based clinical, business management and billing software solutions for the post-acute care industry.
NovaBay Pharmaceuticals Inc, a maker of nonantibiotic, anti-infective products for eye care and wound care, has signed a national distribution pact with AmerisourceBergen Corp.
The Cardinal Health Foundation and the American Pharmacists Association (APhA) recently honored pharmacists for their efforts in preventing misuse of prescription drugs.
Ramona Sequeira has been appointed president of Takeda Pharmaceuticals U.S.A. Inc., a unit of Takeda Pharmaceutical Co. The company said this week that Sequeira will lead all business operations for the United States and report to Christophe Weber, president and chief executive officer of Takeda.
London Drugs stores already boast a unique product mix with their substantial consumer-electronics departments, which feature products ranging from digital cameras and flat-screen TVs to computers and mobile devices. Yet now the retailer is adding another twist: a drone.
